CSL
Esther Heijnen is a seasoned professional in clinical development, currently serving as Vice President and Head of Clinical Development for Vaccines at CSL since June 2023. Prior experience includes roles as Senior Director of Clinical Development for Respiratory Vaccines at The Janssen Pharmaceutical Companies of Johnson & Johnson and as Senior Director for Seasonal Influenza Vaccines at Seqirus. Esther's career encompasses leadership positions at Novartis, Merck, Organon, and a research background as a physician at UMC Utrecht and Erasmus MC. Educational qualifications include a Doctor of Medicine from Erasmus University Rotterdam, a PhD in Medicine from Utrecht University, and a Master’s in Pharmaceutical Medicine from the European Center for Pharmaceutical Medicine.
This person is not in any offices
CSL
61 followers
CSL Behring Australia is a biopharmaceutical leader driven by its promise to save and improve lives.